Objective
to compare the clinical outcomes of transcatheter tricuspid valve replacement plus medical treatment versus medical therapy alone for the treatment of severe tricuspid regurgitation
Study
international multicentre randomised trial 2:1 ratio
Population
patients with severe symptomatic tricuspid valve regurgitation
Endpoints
hierarchical composite outcome of six various clinical outcomes
Conclusion
transcatheter tricuspid valve replacement was superior to medical therapy alone for the treatment of severe symptomatic tricuspid regurgitation
Hahn et al. NEJM. 2024 Oct 30.
